Vinay Shah

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Vinay Shah
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vinay Shah:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aravive, Inc. Chief Financial Officer Common Stock 190,842 $175,556 $0.9199 29 Jun 2021 Direct
Aravive, Inc. Chief Financial Officer Stock Option (Right to buy) 175,000 24 Jan 2022 Direct
Virpax Pharmaceuticals, Inc. Chief Financial Officer Stock Option (right to buy) 112,000 29 Jan 2024 Direct
ADIAL PHARMACEUTICALS, INC. Chief Financial Officer Stock Option 40,000 16 Nov 2024 Direct
ADIAL PHARMACEUTICALS, INC. Chief Financial Officer Stock Option (Right to Buy) 9,000 29 May 2025 Direct

Insider Reports Filed by Vinay Shah

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ADIL ADIAL PHARMACEUTICALS, INC. 29 May 2025 1 $0 4 Chief Financial Officer 02 Jun 2025, 16:01
ADIL ADIAL PHARMACEUTICALS, INC. 16 Nov 2024 1 $0 4 Chief Financial Officer 18 Nov 2024, 16:01
ADIL ADIAL PHARMACEUTICALS, INC. 16 Nov 2024 0 $0 3 Chief Financial Officer 18 Nov 2024, 16:00
VRPX Virpax Pharmaceuticals, Inc. 29 Jan 2024 1 $0 4 Chief Financial Officer 31 Jan 2024, 16:25
VRPX Virpax Pharmaceuticals, Inc. 20 Jun 2023 1 $0 4/A Chief Financial Officer 16 Aug 2023, 18:00
VRPX Virpax Pharmaceuticals, Inc. 20 Jun 2023 0 $0 3 Chief Financial Officer 21 Jun 2023, 16:17
/report/000143774922001577-shah-vinay-2022-01-24 Aravive, Inc. 24 Jan 2022 1 $0 4 Chief Financial Officer 25 Jan 2022, 15:05
/report/000143774921015968-shah-vinay-2021-06-29 Aravive, Inc. 29 Jun 2021 1 +$5,310 4 Chief Financial Officer 29 Jun 2021, 19:36